Literatura académica sobre el tema "Aluminum hydroxide adjuvant (Alum)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Aluminum hydroxide adjuvant (Alum)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Aluminum hydroxide adjuvant (Alum)"
Hem, Stanley L., Cliff T. Johnston y Harm HogenEsch. "Imject® Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant". Vaccine 25, n.º 27 (junio de 2007): 4985–86. http://dx.doi.org/10.1016/j.vaccine.2007.04.078.
Texto completoDavison, Clara J., Haley A. Partlow, Stephanie K. Lathrop, Karthik Siram, Walid Abdelwahab, David J. Burkhart y Jay Evans. "Combinations of alum and synthetic toll-like receptor agonists as adjuvants for CoVID-19 vaccines". Journal of Immunology 206, n.º 1_Supplement (1 de mayo de 2021): 30.07. http://dx.doi.org/10.4049/jimmunol.206.supp.30.07.
Texto completoNear, Karen A., Anthony W. Stowers, Dragana Jankovic y David C. Kaslow. "Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model". Infection and Immunity 70, n.º 2 (febrero de 2002): 692–701. http://dx.doi.org/10.1128/iai.70.2.692-701.2002.
Texto completoKaracs, Jasmine, Manuel Reithofer, Claudia Kitzmüller, Markus Kraller, Stefanie Schmalz, Sonja Bleichert, Johannes B. Huppa, Hannes Stockinger, Barbara Bohle y Beatrice Jahn-Schmid. "Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps". Vaccines 9, n.º 4 (1 de abril de 2021): 321. http://dx.doi.org/10.3390/vaccines9040321.
Texto completoPrior, J. Timothy, Christopher Davitt, Jonathan Kurtz, Patrick Gellings, James B. McLachlan y Lisa A. Morici. "Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses". Pharmaceutics 13, n.º 2 (20 de enero de 2021): 131. http://dx.doi.org/10.3390/pharmaceutics13020131.
Texto completoKool, Mirjam, Thomas Soullié, Menno van Nimwegen, Monique A. M. Willart, Femke Muskens, Steffen Jung, Henk C. Hoogsteden, Hamida Hammad y Bart N. Lambrecht. "Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells". Journal of Experimental Medicine 205, n.º 4 (24 de marzo de 2008): 869–82. http://dx.doi.org/10.1084/jem.20071087.
Texto completoZhang, Zhe, Xin-Pu Li, Feng Yang, Jin-Yin Luo, Xu-Rong Wang, Long-hai Liu y Hong-Sheng Li. "Immune Responses in Mice Immunized with Mastitis Multiple Vaccines Using Different Adjuvants". Acta Scientiae Veterinariae 46, n.º 1 (10 de agosto de 2018): 8. http://dx.doi.org/10.22456/1679-9216.84088.
Texto completoChen, Qiuting, Nan Wu, Yuhui Gao, Xiaojun Wang, Jie Wu y Guanghui Ma. "Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy". Vaccines 9, n.º 11 (26 de octubre de 2021): 1244. http://dx.doi.org/10.3390/vaccines9111244.
Texto completoHawksworth, David y Joan Tyner. "Evaluation of Adjuvant Regimens for Antibody Development in Rabbits (36.29)". Journal of Immunology 178, n.º 1_Supplement (1 de abril de 2007): S17—S18. http://dx.doi.org/10.4049/jimmunol.178.supp.36.29.
Texto completoSasaki, Eita, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami y Isao Hamaguchi. "Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses". PLOS Pathogens 17, n.º 8 (30 de agosto de 2021): e1009890. http://dx.doi.org/10.1371/journal.ppat.1009890.
Texto completoTesis sobre el tema "Aluminum hydroxide adjuvant (Alum)"
Bortolatto, Juliana. "Toll-like receptor 4 (TLR4) na modulação da imunidade do tipo 2". Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/42/42133/tde-18112008-172851/.
Texto completoEpidemiological and experimental data suggest that bacterial lipopolysaccharides (LPS) can either protect from or exacerbate allergic asthma. LPS triggers immune responses through Toll-like receptor (TLR) 4 that in turn activates two major signaling pathways via either MyD88 or TRIF adaptor proteins. LPS is a pro-Th1 adjuvant while aluminum hydroxide (Alum) is a strong Th2 adjuvant, but the effect of mixing both adjuvants on development of lung allergy has not been investigated. We determined whether natural (LPS) or synthetic (ER-803022) TLR4 agonists adsorbed onto alum adjuvant affect allergen sensitization and development of airway allergic disease. To dissect LPS-induced molecular pathways we used TLR4, MyD88, TRIF, or IL-12/IFN-g deficient mice. Mice were sensitized subcutaneously to allergens such as ovalbumin (OVA) or tetanus toxoid (TT) with or without TLR4 agonists coadsorbed onto Alum and challenged twice via intranasal route with the same allergens. The development of type 2 immunity was evaluated 24 h after last allergen challenge. We found that sensitization with OVA or TT plus LPS co-adsorbed onto Alum impaired allergeninduced Th2-mediated responses such as airway eosinophilia, type 2 cytokines secretion, airway hyperreactivity, mucus hyper production and serum levels of IgE or IgG1 anaphylactic antibodies. Although the levels of IgG2a, a Th1 affiliated isotype increased, investigation into the lung-specific effects revealed that LPS did not induce a Th1 pattern of inflammation. LPS impaired the development of Th2 immunity, signaling via TLR4 and MyD88 molecules via the IL-12/IFN-g axis, but not through TRIF pathway. Moreover, the synthetic TLR4 agonists that proved to have a less systemic inflammatory response than LPS also protected against allergic asthma development. TLR4 agonists co-adsorbed with allergen onto Alum down modulate Th2 immunity and prevent the development of polarized T cell-mediated airway inflammation. Thus, our work clarifies the effect of TLR4 signaling in allergic sensitization and indicates that TLR4 agonists with low toxicity might be useful for down regulating the pro-Th2 adjuvant activity of alum and consequently decrease the induction of allergy.
Li, Xinran. "Vaccine formulation development : towards addressing major limitations of vaccines that are adjuvanted with aluminum salts". Thesis, 2013. http://hdl.handle.net/2152/28737.
Texto completotext
Libros sobre el tema "Aluminum hydroxide adjuvant (Alum)"
Centre, Alberta Environmental. Binding, uptake and toxicity of alum sludge. [Vegreville, Alta.]: The Centre, 1987.
Buscar texto completoCapítulos de libros sobre el tema "Aluminum hydroxide adjuvant (Alum)"
Setyawati, Damai Ria, Sjaikhurrizal El Muttaqien, Donny Ramadhan y Etik Mardliyati. "Effect of Sterilization on Protein Adsorption of Micro- and Nano-sized Aluminum Hydroxide Adjuvant". En Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022), 824–32. Dordrecht: Atlantis Press International BV, 2023. http://dx.doi.org/10.2991/978-94-6463-112-8_75.
Texto completo